University of Wisconsin–Madison

Year: 2026

David Abbott retires after decades of field-changing PMOS/PCOS research

After more than three decades of groundbreaking research, mentorship, and leadership at UW–Madison and the WNPRC, David Abbott, PhD has retired leaving behind a legacy in reproductive science. This interview reflects on Abbott’s contributions to Polyendocrine Metabolic Ovary Syndrome (PMOS, formerly known as Polycystic Ovary Syndrome or PCOS), his students and trainees, and a career …

Heart Regeneration Research in Nonhuman Primates: A Model for Ventricular Pressure Overload

Congenital heart defects are the most common type of birth defect in the United States and can result in heart failure early in life. Stem cell grafts offer potential as a treatment for cardiac defects, but both laboratory bench experiments and whole-animal studies are necessary for progress in this area. By testing cardiac treatments in …

A First for Parkinson’s: Autologous Cell Therapy Moves from the Wisconsin National Primate Research Center to Human Trials

A new investigational treatment for Parkinson’s disease is showing early promise in its first human clinical trial, thanks in part to foundational work at the University of Wisconsin–Madison and the Wisconsin National Primate Research Center (WNPRC).

Zika infections can cause significant developmental problems

Even babies born without the virus’s notable physical symptoms may experience sensory, attachment and anxiety issues, according to a new study.